To evaluate six-color digital PCR for the monitoring of EGFR mutations in NSCLC patients under treatment, the plasma samples of 4 patients, drawn at various timepoints, were analyzed (Figure 3). This evidence concerns the gene EGFR and non-small cell lung carcinoma.